Verastem Inc
VSTM
NASDAQ
Biotechnology
$6.58
USD
-0.09 (-1.35%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $586.12M
Volume 1.3M
Revenue
$87.53M
TTM
+3995.7%
YoY
Gross Margin
87%
TTM
+10.0%
YoY
Net Income
$-202.70M
TTM
-21.7%
YoY
Operating Cash Flow
$-162.19M
TTM
-34.9%
YoY
Revenue & Net Income
USD Millions
Margins Trend
Percent of revenue
Income Statement Detail
USD Millions, except per-share and share count figures
Metric | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|
Revenue | 2.1 | 11.2 | 17.5 | 18.7 | 40.1 |
YoY Growth | -78.6% | — | — | — | +1775.4% |
Cost of Revenue | 0.4 | 1.7 | 2.6 | 3.1 | 4.0 |
Gross Profit | 1.7 | 9.6 | 14.9 | 15.6 | 36.0 |
Selling, General & Administrative | 20.7 | 21.0 | 24.4 | 22.3 | 27.4 |
Other Operating Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Total Operating Expenses | 45.5 | 50.3 | 56.4 | 60.5 | 68.7 |
Operating Income | -43.8 | -40.7 | -41.5 | -44.9 | -32.7 |
EBITDA | -43.6 | -40.8 | -40.8 | -44.6 | -32.4 |
Other Income / Expense | 17.2 | -58.7 | 7.9 | 7.4 | -1.9 |
Total Other Income / Expense | 17.8 | -57.8 | 8.6 | 8.3 | -1.1 |
Income Before Income Taxes | -25.9 | -98.5 | -32.9 | -36.6 | -33.9 |
Income Taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.8 |
Net Income | -25.9 | -98.5 | -32.9 | -36.6 | -34.7 |
Consolidated Net Income / Loss | -25.9 | -98.5 | -32.9 | -36.6 | -34.7 |
Net Income Attributable to Common Shareholders | -25.9 | -98.5 | -32.9 | -36.6 | -34.7 |
Basic EPS | -$0.39 | -$1.35 | -$0.39 | -$0.37 | -$0.35 |
Diluted EPS | -$0.62 | -$1.35 | -$0.43 | -$0.46 | -$0.35 |
Basic Shares Outstanding | 66.1M | 73.2M | 83.8M | 98.3M | 100.1M |
Diluted Shares Outstanding | 74.0M | 73.2M | 75.9M | 99.1M | 100.1M |